[Clinical experience report on the use of a new cytostatic 3393].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D010954:Plasmacytoma / Q000188:drug therapy; D012709:Serum Albumin; D012712:Serum Globulins; D013997:Time Factors
D000970:Antineoplastic Agents; D012709:Serum Albumin; D012712:Serum Globulins
Klinischer Erfahrungsbericht über die Anwendung des neuen Zytostatikum 3393.